Insight Guide

Address Development Challenges from Early Development Phase

Format: PDF file | Document type: Insight Guide | Promoted Content

This content is provided by Catalent, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Address Development Challenges from Early Development Phase

Although many challenges arise once drugs are on the market, adherence has emerged as a major focus of scientists and developers. After all, improving the rate at which patients comply with dosing requirements could solve many other problems. It would, first and foremost, improve patient outcomes, which might in turn improve the competitive outlook for new drugs, as well as reimbursement scenarios. This eBook highlights how using novel technologies to more effectively deliver an existing drug can increase patient adherence while speeding up reformulation time & reducing costs.

Latest content from Catalent

Related resources from Catalent

Show more

Supplier info centre